Table I.
Clinicopathological characteristics of chemoresistant and chemosensitive ovarian cancer patients.
| Characteristics | Cases | Chemosensitive, n (%) | Chemoresistant, n (%) | χ2 | P-value |
|---|---|---|---|---|---|
| Age (years) | 34 | 24 | |||
| <50 | 39 | 23 (59.0) | 16 (41.0) | 0.793 | 0.459 |
| ≥50 | 19 | 11 (57.8) | 8 (42.2) | ||
| FIGO stage | |||||
| I | 14 | 10 (71.40) | 4 (28.6) | 1.926 | 0.503 |
| II | 18 | 10 (55.6) | 8 (44.4) | ||
| III | 17 | 9 (52.9) | 8 (47.1) | ||
| IV | 9 | 5 (55.6) | 4 (44.4) | ||
| Histological grade | |||||
| G1 | 6 | 4 (66.7) | 2 (33.7) | 0.732 | 0.625 |
| G2 | 20 | 11 (55.0) | 9 (45.0) | ||
| G3 | 32 | 19 (59.3) | 13 (40.7) | ||
| Histology | |||||
| Serous | 30 | 19 (63.3) | 11 (36.7) | 2.037 | 0.561 |
| Mucinous | 11 | 6 (54.5) | 5 (35.5) | ||
| Endometrioid | 10 | 6 (60) | 4 (40) | ||
| Clear cell | 3 | 1 (33.3) | 2 (66.7) | ||
| Anaplastic | 4 | 2 (50.0) | 2 (50.0) | ||
| Lymph node metastasis | |||||
| Yes | 26 | 11 (42.3) | 15 (57.7) | 2.453 | 0.471 |
| No | 32 | 23 (71.8) | 9 (28.2) |
FIGO, International Federation of Gynecology and Obstetrics.